Many thanks to everyone who responded to the UK NSC stakeholder survey. We will analyse the results and use them to inform any changes needed to the UK NSC stakeholder engagement strategy and activities.
April is Bowel Cancer Awareness Month and it's a good time to highlight the evidence that clearly demonstrates the effectiveness of bowel cancer screening.
Well over 1 million babies have now been screened for severe combined immune deficiency (SCID) since the September 2021 launch of an in-service evaluation (ISE) in NHS services.
An update from the partnership board that is overseeing the planning of an in-service evaluation (ISE) of newborn screening for spinal muscular atrophy.
More than 200 stakeholders attended a fascinating UK National Screening Committee (UK NSC) seminar exploring multi-cancer detection tests (MCDs) and their potential use in a screening context. Attendees included academics, clinicians, researchers, industry representatives, patient organisations, screening providers, policy makers …
Find out more about the role local government public health teams play in screening.
Related content and links
About this blog
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
screening programmes.